GCP
ANGO icon

GSA Capital Partners’s AngioDynamics ANGO Stock Holding History

GSA Capital Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,647
Closed -$381K – 1687
2025
Q4 		$381K Buy
+29,647
New +$366K 0.03% 1008
2025
Q3 		– Sell
-22,373
Closed -$222K – 1632
2025
Q2 		$222K Sell
22,373
-45,955
-67% -$450K 0.02% 1452
2025
Q1 		$642K Buy
+68,328
New +$718K 0.06% 623
2024
Q4 		– Sell
-91,769
Closed -$714K – 1580
2024
Q3 		$714K Buy
91,769
+33,719
+58% +$243K 0.05% 674
2024
Q2 		$351K Buy
+58,050
New +$358K 0.02% 1184
2024
Q1 		– Sell
-126,339
Closed -$990K – 1580
2023
Q4 		$990K Sell
126,339
-81,748
-39% -$567K 0.08% 398
2023
Q3 		$1.52M Buy
208,087
+39,769
+24% +$331K 0.13% 199
2023
Q2 		$1.76M Buy
168,318
+126,926
+307% +$1.22M 0.18% 91
2023
Q1 		$428K Sell
41,392
-7,783
-16% -$99.6K 0.04% 813
2022
Q4 		$677K Sell
49,175
-1,499
-3% -$20.9K 0.08% 417
2022
Q3 		$1.04M Buy
50,674
+4,118
+9% +$90.4K 0.14% 142
2022
Q2 		$901K Buy
46,556
+6,934
+18% +$142K 0.14% 180
2022
Q1 		$853K Buy
39,622
+907
+2% +$20.6K 0.11% 238
2021
Q4 		$1.07M Sell
38,715
-11,442
-23% -$316K 0.13% 181
2021
Q3 		$1.3M Sell
50,157
-42,746
-46% -$1.14M 0.13% 179
2021
Q2 		$2.52M Buy
+92,903
New +$2.27M 0.28% 30
2021
Q1 		– Sell
-27,717
Closed -$425K – 1080
2020
Q4 		$425K Buy
+27,717
New +$352K 0.07% 527
2020
Q1 		– Sell
-12,054
Closed -$193K – 1038
2019
Q4 		$193K Sell
12,054
-22,758
-65% -$348K 0.02% 1266
2019
Q3 		$641K Buy
+34,812
New +$681K 0.09% 392
2019
Q2 		– Sell
-27,708
Closed -$633K – 1419
2019
Q1 		$633K Buy
+27,708
New +$602K 0.06% 546
2017
Q3 		– Sell
-18,706
Closed -$303K – 1581
2017
Q2 		$303K Buy
18,706
+7,999
+75% +$126K 0.02% 1272
2017
Q1 		$186K Sell
10,707
-6,310
-37% -$106K 0.01% 1589
2016
Q4 		$287K Buy
+17,017
New +$284K 0.02% 1353
2015
Q2 		– Sell
-48,201
Closed -$857K – 1930
2015
Q1 		$857K Buy
48,201
+29,480
+157% +$548K 0.03% 992
2014
Q4 		$356K Sell
18,721
-20,848
-53% -$353K 0.02% 1163
2014
Q3 		$543K Buy
39,569
+24,537
+163% +$350K 0.03% 883
2014
Q2 		$245K Buy
+15,032
New +$218K 0.01% 1514
2014
Q1 		– Sell
-17,964
Closed -$309K – 1547
2013
Q4 		$309K Buy
+17,964
New +$276K 0.02% 1178

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

GSA Capital Partners's ANGO Position: Q1 2026 in Review

GSA Capital Partners sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 29,647 shares — an estimated $381K sold.

GSA Capital Partners first reported a position in ANGO in Q4 2013 and held it in 28 quarters. The position peaked at $2.52M in Q2 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • GSA Capital Partners reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 29,647 AngioDynamics shares in Q1 2026, an estimated $381K.
  • GSA Capital Partners first reported a position in AngioDynamics in Q4 2013 and held it in 28 quarters.
  • GSA Capital Partners's AngioDynamics position peaked at $2.52M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.